Bought lots of shares this week. Trying to understand who would be selling. Doesn't seem like a good risk reward scenario for a shorty. I see the risk reward favors the long position. In contrast to some bio-med companies, Brilacidin & Kevetrin are developed drugs already and the safety profiles are completed and excellent. Accelerators include the phase 2b trial, the Virology conference, solid management and advisors, and enough cash on hand to reach the phase 2b goals. IMO share price breakout could happen anytime this summer! Anyone buying $IPIX for less than $1 or even $5 will be greatly rewarded.